Form 4: Protagonist Therapeutics CFO Asif Ali Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Asif Ali, CFO of Protagonist Therapeutics, sold 1,756 shares of common stock on April 22, 2025, to cover tax withholding obligations.
Summary
- Asif Ali, the Chief Financial Officer of Protagonist Therapeutics, Inc. (PTGX), reported a transaction involving the sale of company stock.
- On April 22, 2025, Ali sold 1,756 shares of common stock at a price of $46 per share.
- The sale was executed to cover tax withholding obligations incurred upon the settlement of restricted stock units.
- Following the transaction, Ali directly owns 61,065 shares of Protagonist Therapeutics.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.
Industry Context
This is a routine Form 4 filing, which is common for company executives who sell shares. It doesn't necessarily indicate a negative outlook for the company, as the sale was to cover tax obligations.
Stakeholder Impact
- The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 04/22/2025 | Date of stock sale transaction. |
| 04/23/2025 | Date of signature on the Form 4 filing. |
Keywords
Protagonist Therapeutics, PTGX, Asif Ali, CFO, stock sale, Form 4, tax withholding, restricted stock units, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.